Rapid detection of FKS-associated echinocandin resistance in Candida glabrata

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 11, 2016, Pages 6573-6577

  Zhao, Yanan ^a   Nagasaki, Yoji ^a   Kordalewska, Milena ^a   Press, Ellen G ^b   Shields, Ryan K ^b   Nguyen, M Hong ^b   Clancy, Cornelius J ^b,c   Perlin, David S ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIDULAFUNGIN; CASPOFUNGIN; ECHINOCANDIN; MICAFUNGIN; ANTIFUNGAL AGENT; FUNGAL DNA; FUNGAL PROTEIN; GLUCOSYLTRANSFERASE; ISOENZYME; MOLECULAR PROBE;

ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA GLABRATA; DNA SEQUENCE; FKS1 GENE; FKS2 GENE; FUNGAL GENE; GENE MUTATION; GENOTYPE; IN VITRO STUDY; MOLECULAR BEACON; MOLECULAR DIAGNOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WILD TYPE; ALLELE; CANDIDIASIS; CHEMISTRY; DNA DENATURATION; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR PROBE; MUTATION; PROCEDURES; SENSITIVITY AND SPECIFICITY;

ALLELES; ANTIFUNGAL AGENTS; CANDIDA GLABRATA; CANDIDIASIS; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; FUNGAL PROTEINS; GENE EXPRESSION; GLUCOSYLTRANSFERASES; HUMANS; ISOENZYMES; MICROBIAL SENSITIVITY TESTS; MOLECULAR PROBES; MUTATION; NUCLEIC ACID DENATURATION; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84994508552     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01574-16     Document Type: Article

References (24)

1. Lockhart SR, Iqbal N, Cleveland AA, Farley MM, Harrison LH, Bolden CB, Baughman W, Stein B, Hollick R, Park BJ, Chiller T. 2012. Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol 50:3435-3442. http://dx.doi.org/10.1128/JCM.01283-12.
2. Guinea J. 2014. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect 20(Suppl 6):S5-S10.
3. Pfaller M, Neofytos D, Diekema D, Azie N, Meier-Kriesche HU, Quan SP, Horn D. 2012. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance) registry, 2004-2008. Diagn Microbiol Infect Dis 74:323-331. http://dx.doi.org/10.1016/j.diagmicrobio.2012.10.003.
4. Alexander BD, Johnson MD, Pfeiffer CD, Jimenez-Ortigosa C, Catania J, Booker R, Castanheira M, Messer SA, Perlin DS, Pfaller MA. 2013. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis 56:1724-1732. http://dx.doi.org/10.1093/cid/cit136.
5. Pfaller MA, Castanheira M, Lockhart SR, Ahlquist AM, Messer SA, Jones RN. 2012. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. J Clin Microbiol 50:1199-1203. http://dx.doi.org/10.1128/JCM.06112-11.
6. Pham CD, Iqbal N, Bolden CB, Kuykendall RJ, Harrison LH, Farley MM, Schaffner W, Beldavs ZG, Chiller TM, Park BJ, Cleveland AA, Lockhart SR. 2014. Role of FKS mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance. Antimicrob Agents Chemother 58:4690-4696. http://dx.doi.org/10.1128/AAC.03255-14.
7. CLSI. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts. Document M27-A3. CLSI, Wayne, PA.
8. Arendrup MC, Cuenca-Estrella M, Lass-Florl C, Hope W. 2012. EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST). Clin Microbiol Infect 18:E246-E247. http://dx.doi.org/10.1111/j.1469-0691.2012.03880.x.
9. Pfaller MA, Diekema DJ, Andes D, Arendrup MC, Brown SD, Lockhart SR, Motyl M, Perlin DS. 2011. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat 14:164-176. http://dx.doi.org/10.1016/j.drup.2011.01.004.
10. Espinel-Ingroff A, Arendrup MC, Pfaller MA, Bonfietti LX, Bustamante B, Canton E, Chryssanthou E, Cuenca-Estrella M, Dannaoui E, Fothergill A, Fuller J, Gaustad P, Gonzalez GM, Guarro J, Lass-Florl C, Lockhart SR, Meis JF, Moore CB, Ostrosky-Zeichner L, Pelaez T, Pukinskas SR, St-Germain G, Szeszs MW, Turnidge J. 2013. Interlaboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob Agents Chemother 57:5836-5842. http://dx.doi.org/10.1128/AAC.01519-13.
11. Arendrup MC, Garcia-Effron G, Lass-Florl C, Lopez AG, Rodriguez-Tudela JL, Cuenca-Estrella M, Perlin DS. 2010. Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and Iso-Sensitest media. Antimicrob Agents Chemother 54:426-439. http://dx.doi.org/10.1128/AAC.01256-09.
12. Shields RK, Nguyen MH, Press EG, Kwa AL, Cheng S, Du C, Clancy CJ. 2012. The presence of an FKS mutation rather thanMICis an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata. Antimicrob Agents Chemother 56:4862-4869. http://dx.doi.org/10.1128/AAC.00027-12.
13. Marras SA, Kramer FR, Tyagi S. 2003. Genotyping SNPs with molecular beacons. Methods Mol Biol 212:111-128.
14. El-Hajj HH, Marras SA, Tyagi S, Shashkina E, Kamboj M, Kiehn TE, Glickman MS, Kramer FR, Alland D. 2009. Use of sloppy molecular beacon probes for identification of mycobacterial species. J Clin Microbiol 47:1190-1198. http://dx.doi.org/10.1128/JCM.02043-08.
15. Chakravorty S, Kothari H, Aladegbami B, Cho EJ, Lee JS, Roh SS, Kim H, Kwak H, Lee EG, Hwang SH, Banada PP, Safi H, Via LE, Cho SN, Barry CE, III, Alland D. 2012. Rapid, high-throughput detection of rifampin resistance and heteroresistance in Mycobacterium tuberculosis by use of sloppy molecular beacon melting temperature coding. J Clin Microbiol 50:2194-2202. http://dx.doi.org/10.1128/JCM.00143-12.
16. Brillowska-Dabrowska A, Saunte DM, Arendrup MC. 2007. Five-hour diagnosis of dermatophyte nail infections with specific detection of Trichophyton rubrum. J Clin Microbiol 45:1200-1204. http://dx.doi.org/10.1128/JCM.02072-06.
17. Healey KR, Zhao Y, Perez WB, Lockhart SR, Sobel JD, Farmakiotis D, Kontoyiannis DP, Sanglard D, Taj-Aldeen SJ, Alexander BD, Jimenez-Ortigosa C, Shor E, Perlin DS. 2016. Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance. Nat Commun 7:11128. http://dx.doi.org/10.1038/ncomms11128.
18. Beyda ND, John J, Kilic A, Alam MJ, Lasco TM, Garey KW. 2014. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia. Clin Infect Dis 59:819-825. http://dx.doi.org/10.1093/cid/ciu407.
19. Pfaller MA, Diekema DJ, Jones RN, Castanheira M. 2014. Use of anidulafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 4,290 clinical isolates of Candida by using CLSI methods and interpretive criteria. J Clin Microbiol 52:3223-3229. http://dx.doi.org/10.1128/JCM.00782-14.
20. Arendrup MC, Perlin DS. 2014. Echinocandin resistance: an emerging clinical problem? Curr Opin Infect Dis 27:484-492. http://dx.doi.org/10.1097/QCO.0000000000000111.
21. Pham CD, Bolden CB, Kuykendall RJ, Lockhart SR. 2014. Development of a Luminex-based multiplex assay for detection of mutations conferring resistance to echinocandins in Candida glabrata. J Clin Microbiol 52:790-795. http://dx.doi.org/10.1128/JCM.03378-13.
22. Zimbeck AJ, Iqbal N, Ahlquist AM, Farley MM, Harrison LH, Chiller T, Lockhart SR. 2010. FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance. Antimicrob Agents Chemother 54:5042-5047. http://dx.doi.org/10.1128/AAC.00836-10.
23. Castanheira M, Woosley LN, Messer SA, Diekema DJ, Jones RN, Pfaller MA. 2014. Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates. Antimicrob Agents Chemother 58:577-580. http://dx.doi.org/10.1128/AAC.01674-13.
24. Dudiuk C, Gamarra S, Leonardeli F, Jimenez-Ortigosa C, Vitale RG, Afeltra J, Perlin DS, Garcia-Effron G. 2014. Set of classical PCRs for detection of mutations in Candida glabrata FKS genes linked with echinocandin resistance. J Clin Microbiol 52:2609-2614. http://dx.doi.org/10.1128/JCM.01038-14.